Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by chris579457on Jun 21, 2023 2:57pm
233 Views
Post# 35507703

Special meeting

Special meeting I received voting instructions form, special meeting and financials. The management is asking us to approve their recommendations.
It is disturbing trend calling us disinterested shareholders! after they lost all of our investment, the company lost their respect and share price.
We had already 15:1 share consolidation then we lost 90% of that too and now they are asking for another approval 10:1 share consolidation.
This is a shady trend to bankrupt existing shareholders and look for new ones with new company name and new money to fulfill their compensation plans with new promises .
The Omnibus Plan is a plan to bypass our wishes and voting rights.
Unfortunately someone already has mentioned about the managements previous illegal activities from the past , 10 years ago or so.    
 
I am very disappointed with this, any thoughts ?

<< Previous
Bullboard Posts
Next >>